# RNN 2nd Gen Model UnitedHealth Group Incorporated Hospital & medical service plans

Stock predictor AI models:
Subscribe >> Deal exit on
Dec. 14, 2020
Deal entry on
Dec. 14, 2020
5.48%Expected margin
58.33% successful of 12 deals
$ 351.30 Last close price
at 15-jan-2021


Model's trade recommendations No return for period yet

-16.79% Annual return

$339.08B Market Cap

β 0.74  


Model (following trade recommendations)


Underlying stock

S&P 500

Return for period
52wk return -23.96%
52wk Range
Sortino ratio -0.65
Sharpe ratio -0.62
Norm. RMSE 7.32%
Downside risk 23.40%
Volatility 0.00%
  • 5.00 (1.40%) Div (Yield)
  • STRONG BUY Analysts consensus recommendation

UnitedHealthcare Group Inc. is dedicated to helping people nationwide live healthier lives by simplifying the health care experience, meeting consumer health and wellness needs and sustaining trusted relationships with care providers. The company offers the full spectrum of health benefit programs for individuals, employers, military service members, retirees and their families, and Medicare and Medicaid beneficiaries, and contracts directly with the physicians and care professionals, and hospitals and other care facilities nationwide.

Industry sector: Medical

Sector classification: Hospital & medical service plans

Deep Learning based analysis and prediction model for UnitedHealth Group Incorporated (UNH) stock is a 2nd Generation Non-linear Autoregressive (NAR) model based on the LSTM/GRU Recurrent Neural Network architecture.

Model is in the production pipeline since Sept. 10, 2014.

Market data for UNH model training are being downloaded from the Quandl premium datasets on a daily basis.
Risks related to the novel coronavirus disease 2019 (COVID-19) caused by the virus named “SARS-CoV-2” are accounted for in this model in the form of the historical data coincided with outbreaks and other global events in the past used to train ML prediction model for UNH.

Model is being retrained on a regular basis.

Float 941M
P/E 19.58
Shares Outstanding 949M
% Held by Insiders 0.80%
% Held by Institutions 86.03%
EPS (last reported FY) $15.11
EPS (last reported Q) $3.51
EPS, estimated (last reported Q) $2.98
Total revenues $242 B
Net income $14 B